Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation.

CD39, or vascular adenosine triphosphate diphosphohydrolase, has been considered an important inhibitor of platelet activation. Unexpectedly, cd39-deficient mice had prolonged bleeding times with minimally perturbed coagulation parameters. Platelet interactions with injured mesenteric vasculature were considerably reduced in vivo and purified mutant platelets failed to aggregate to standard agonists in vitro. This platelet hypofunction was reversible and associated with purinergic type P2Y1 receptor desensitization. In keeping with deficient vascular protective mechanisms, fibrin deposition was found at multiple organ sites in cd39-deficient mice and in transplanted cardiac grafts. Our data indicate a dual role for adenosine triphosphate diphosphohydrolase in modulating hemostasis and thrombotic reactions.

Pubmed ID: 10470077


  • Enjyoji K
  • Sévigny J
  • Lin Y
  • Frenette PS
  • Christie PD
  • Esch JS
  • Imai M
  • Edelberg JM
  • Rayburn H
  • Lech M
  • Beeler DL
  • Csizmadia E
  • Wagner DD
  • Robson SC
  • Rosenberg RD


Nature medicine

Publication Data

September 24, 1999

Associated Grants

  • Agency: NHLBI NIH HHS, Id: HL41002
  • Agency: NHLBI NIH HHS, Id: HL57307
  • Agency: PHS HHS, Id: P01-41484

Mesh Terms

  • Adenosine Triphosphatases
  • Animals
  • Antigens, CD
  • Apyrase
  • Arterioles
  • Bleeding Time
  • Blood Coagulation
  • Blood Platelets
  • Cells, Cultured
  • Endothelium, Vascular
  • Female
  • Fibrin
  • Gene Deletion
  • Graft Rejection
  • Heart Transplantation
  • Hemostasis
  • Male
  • Mesentery
  • Mice
  • Mice, Knockout
  • Platelet Aggregation
  • Rats
  • Receptors, Purinergic P2
  • Receptors, Purinergic P2Y1
  • Thromboplastin
  • Thrombosis